Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming
Copyright © 2024 Elsevier Inc. All rights reserved..
Cancer-associated fibroblasts (CAFs) are the main components in the tumor microenvironment. Tumors activate fibroblasts from quiescent state into activated state by secreting cytokines, and activated CAFs may in turn promote tumor progression and metastasis. Therefore, studies targeting CAFs could enrich the therapeutic options for tumor treatment. In this study, we demonstrate that the content of lipid droplets and the expression of autophagosomes were higher in CAFs than in peri-tumor fibroblasts (PTFs), which was inhibited by 5-(tetradecyloxy)-2-furoic acid(TOFA). The expression of CD36 in CAFs was higher than that in PTFs at both mRNA and protein levels. Inhibition of CD36 activity using either the CD36 inhibitor SSO or siRNA had a significant negative impact on the proliferation and migration abilities of CAFs, which was associated with reduced levels of relevant activated genes (α-SMA, FAP, Vimentin) and cytokines (IL-6, TGF-β and VEGF-α). SSO also inhibited HCC growth and tumorigenesis in nude mice orthotopically implanted with CAFs and HCC cells. Our data further show that CD36+CAFs affected the expression of PD-1 in CTLs leading to CTL exhaustion, and that patients with high CD36 expression in CAFs were correlated with shorter overall survival (OS). Together, our data demonstrate that CAFs were active in lipid metabolism with increased lipid content and lipophagy activity. CD36 may play a key role in the regulation of the biological behaviors of CAFs, which may influence the proliferation and migration of tumor cells by reprograming the lipid metabolism in tumor cells. Thus, CD36 could be an effective therapeutic target for the treatment of HCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:435 |
|---|---|
| Enthalten in: |
Experimental cell research - 435(2024), 2 vom: 15. Feb., Seite 113947 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Han [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CD36 |
|---|
| Anmerkungen: |
Date Completed 16.02.2024 Date Revised 16.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.yexcr.2024.113947 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36791350X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36791350X | ||
| 003 | DE-627 | ||
| 005 | 20240216232759.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240202s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.yexcr.2024.113947 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1295.xml |
| 035 | |a (DE-627)NLM36791350X | ||
| 035 | |a (NLM)38301989 | ||
| 035 | |a (PII)S0014-4827(24)00037-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Han |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.02.2024 | ||
| 500 | |a Date Revised 16.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
| 520 | |a Cancer-associated fibroblasts (CAFs) are the main components in the tumor microenvironment. Tumors activate fibroblasts from quiescent state into activated state by secreting cytokines, and activated CAFs may in turn promote tumor progression and metastasis. Therefore, studies targeting CAFs could enrich the therapeutic options for tumor treatment. In this study, we demonstrate that the content of lipid droplets and the expression of autophagosomes were higher in CAFs than in peri-tumor fibroblasts (PTFs), which was inhibited by 5-(tetradecyloxy)-2-furoic acid(TOFA). The expression of CD36 in CAFs was higher than that in PTFs at both mRNA and protein levels. Inhibition of CD36 activity using either the CD36 inhibitor SSO or siRNA had a significant negative impact on the proliferation and migration abilities of CAFs, which was associated with reduced levels of relevant activated genes (α-SMA, FAP, Vimentin) and cytokines (IL-6, TGF-β and VEGF-α). SSO also inhibited HCC growth and tumorigenesis in nude mice orthotopically implanted with CAFs and HCC cells. Our data further show that CD36+CAFs affected the expression of PD-1 in CTLs leading to CTL exhaustion, and that patients with high CD36 expression in CAFs were correlated with shorter overall survival (OS). Together, our data demonstrate that CAFs were active in lipid metabolism with increased lipid content and lipophagy activity. CD36 may play a key role in the regulation of the biological behaviors of CAFs, which may influence the proliferation and migration of tumor cells by reprograming the lipid metabolism in tumor cells. Thus, CD36 could be an effective therapeutic target for the treatment of HCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CD36 | |
| 650 | 4 | |a Cancer-associated fibroblasts | |
| 650 | 4 | |a Hepatocellular carcinoma | |
| 650 | 4 | |a T cell exhaustion | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 700 | 1 | |a Liu, Fangming |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Xiaoling |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Guiqi |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Zheng |e verfasserin |4 aut | |
| 700 | 1 | |a Qu, Weifeng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Qianfu |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Run |e verfasserin |4 aut | |
| 700 | 1 | |a Tian, Mengxin |e verfasserin |4 aut | |
| 700 | 1 | |a Fang, Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Xifei |e verfasserin |4 aut | |
| 700 | 1 | |a Tao, Chenyang |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Weiren |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Jian |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Jia |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Duojiao |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Yinghong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Experimental cell research |d 1953 |g 435(2024), 2 vom: 15. Feb., Seite 113947 |w (DE-627)NLM000003123 |x 1090-2422 |7 nnns |
| 773 | 1 | 8 | |g volume:435 |g year:2024 |g number:2 |g day:15 |g month:02 |g pages:113947 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.yexcr.2024.113947 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 435 |j 2024 |e 2 |b 15 |c 02 |h 113947 | ||